Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:231-237
doi: 10.1161/hq0202.104062
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoll, M.
Right arrow Articles by Unger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoll, M.
Right arrow Articles by Unger, T.
Related Collections
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide
Right arrow ACE/Angiotension receptors
Right arrow Gene expression
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:231.)
© 2002 American Heart Association, Inc.


Vascular Biology

Identification of a Zinc Finger Homoeodomain Enhancer Protein After AT2 Receptor Stimulation by Differential mRNA Display

Monika Stoll; Alfred W.A. Hahn; Uwe Jonas; Yi Zhao; Bernhard Schieffer; Jens W. Fischer; Thomas Unger

From the Department of Physiology (M.S.), Medical College of Wisconsin, Milwaukee; Knoll AG (A.W.A.H., U.J.), Ludwigshafen, Germany; Department of Cardiology (B.S.), Medizinische Hochschule Hannover; and Institute of Pharmacology (M.S., Y.Z., J.W.F., T.U.), Christian-Albrechts-University Kiel, Kiel, Germany.

Address correspondence to Monika Stoll, PhD, Institute of Pharmacology, Christian-Albrechts-University Kiel, Hospitalstr 4, D-24105 Kiel, Germany. E-mail stoll{at}pharmakologie.uni-kiel.de

Using differential mRNA display, we isolated differentially expressed genes after stimulation of angiotensin II (Ang II) type 2 (AT2) receptors in PC12w cells. Among the polymerase chain reaction products isolated, we identified Zfhep, a zinc finger homoeodomain enhancer–binding protein and the angiotensin AT2 receptor itself, both implicated in developmental processes. In the presence of epidermal growth factor (EGF) a concordant expression pattern of Zfhep and AT2 mRNA was observed with marked downregulation 6 hours after stimulation with EGF+Ang II. In quiescent PC12w cells, Zfhep mRNA was time-dependently induced by Ang II (10-7 mol/L) up to 3 hours, an effect that was blocked by the selective AT2 antagonist PD123177 (10-6 mol/L). We extended our studies on Zfhep mRNA expression to cells of vascular origin (coronary endothelial cells [CECs]), that express AT1 and AT2 receptors, and that respond differently to Ang II dependent on which receptor subtype is stimulated. In CECs, Zfhep mRNA expression was induced up to 3 hours after AT2 stimulation. Interestingly, this Zfhep induction was observed only when the AT1 receptor was blocked by using the selective AT1 receptor antagonist, losartan (10-5 mol/L), suggesting a negative-regulatory influence of AT1 receptors on AT2-induced Zfhep mRNA induction. In conclusion, Zfhep not only represents a suitable marker for AT2 receptor activation, but it may also link AT2 signaling and downstream events involved in the proposed function of the AT2 receptor in development and regeneration.


Key Words: angiotensin II • Zfhep • differential mRNA display • angiotensin receptors




This article has been cited by other articles:


Home page
HypertensionHome page
G. Wolf and U. O. Wenzel
Angiotensin II and Cell Cycle Regulation
Hypertension, April 1, 2004; 43(4): 693 - 698.
[Abstract] [Full Text] [PDF]